The cost impact of disease progression to metastatic castration-sensitive prostate cancer
Authors:
Open Access
- 1 May 2022
- journal article
- research article
- Published by Academy of Managed Care Pharmacy in Journal of Managed Care & Specialty Pharmacy
- Vol. 28 (5) , 544-554
Abstract
BACKGROUND: Metastatic prostate cancer (PC) is associated with declining survival rates and increased health care expenditure. However, there are few studies quantifying these increased costs. OBJE...Keywords
This publication has 20 references indexed in Scilit:
- Survival after bone metastasis by primary cancer type: a Danish population-based cohort studyBMJ Open, 2017
- Impact of subsequent metastases on costs and medical resource use for prostate cancer patients initially diagnosed with localized diseaseCancer, 2017
- The Clinical and Economic Impacts of Skeletal-Related Events Among Medicare Enrollees With Prostate Cancer Metastatic to BoneThe Oncologist, 2016
- Skeletal-related events and mortality among older men with advanced prostate cancerJournal of Geriatric Oncology, 2014
- Healthcare utilization and costs associated with skeletal-related events in prostate cancer patients with bone metastasesProstate Cancer and Prostatic Diseases, 2012
- Modern Detection of Prostate Cancer's Bone Metastasis: Is the Bone Scan Era Over?Advances in Urology, 2011
- Characterising the castration-resistant prostate cancer population: a systematic reviewInternational Journal Of Clinical Practice, 2011
- Mortality following bone metastasis and skeletal-related events among men with prostate cancer: a population-based analysis of US Medicare beneficiaries, 1999–2006Prostate Cancer and Prostatic Diseases, 2011
- LONG-TERM BIOCHEMICAL DISEASE-FREE AND CANCER-SPECIFIC SURVIVAL FOLLOWING ANATOMIC RADICAL RETROPUBIC PROSTATECTOMYUrologic Clinics of North America, 2001
- Metastatic patterns of prostate cancer: An autopsy study of 1,589 patientsHuman Pathology, 2000